Cadralazine

Cadralazine
Systematic (IUPAC) name


ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Number	64241-34-5^Y
ATC code	C02DB04 (WHO)
PubChem	CID 2515
ChemSpider	2420^N
UNII	8T96I3U713^Y
ChEMBL	CHEMBL2106561^N
Chemical data
Formula	C₁₂H₂₁N₅O₃
Molar mass	283.33 g/mol
SMILES O=C(OCC)NNc1nnc(N(CC(O)C)CC)cc1
InChI InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)^N Key:QLTVVOATEHFXLT-UHFFFAOYSA-N^N
^NY (what is this?) (verify)

Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.

References

Nonsympatholytic vasodilatory antihypertensives (C02)

Nitrovasodilator

NO (arterioles and venules)	Nitroprusside #

N (arteriolar)	Hydrazines Hydralazine # Dihydralazine Endralazine Cadralazine Pildralazine

(arteriolar) Potassium channel opener

(arteriolar) Calcium channel blocker

see list

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.